Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education
The goal of this clinical trial is to learn if patient education and regular text reminders are a feasible intervention to engage patients and reduce post partum hypertension. The main questions it aims to answer are: Is a structured postpartum remote blood pressure monitoring intervention with education and individualized medication initiation/adjustment follow-up by televisit feasible? Does a structured program reduce the occurrence of postpartum hypertension, ED visits, hospital readmissions, and adverse…
Conditions studied
Pre-Eclampsia; Complicating Pregnancy, Gestational Hypertension
About this study
The goal of this clinical trial is to learn if patient education and regular text reminders are a feasible intervention to engage patients and reduce post partum hypertension. The main questions it aims to answer are: Is a structured postpartum remote blood pressure monitoring intervention with education and individualized medication initiation/adjustment follow-up by televisit feasible? Does a structured program reduce the occurrence of postpartum hypertension, ED visits, hospital readmissions, and adverse outcomes? Participants will: View an educational video on HDP post-delivery Receive 1-2 times daily text messages for 6 weeks postpartum Have their blood pressure medications adjusted to lower targets post partum
Interventions
- Other: Video — Those in the intervention arm will watch a short educational video.
- Other: Text Reminder — Those in the intervention group will receive regular text message reminders to check their blood pressures
- Other: Blood pressure threshold — Those in the intervention group will have a lower blood pressure threshold to titrate their BP medications towards
Primary outcomes
- Engagement (6 weeks)
- Acceptability (6 weeks)
- Duration of Participation (6 weeks)
Eligibility information
Study locations
- Ochsner Baptist, New Orleans, Louisiana 70115 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.